CC BY 4.0 · Endosc Int Open 2025; 13: a25866007
DOI: 10.1055/a-2586-6007
Review

Biliary stent insertion after stone clearance in patients awaiting cholecystectomy: Systematic review and meta-analysis

1   Department of Health Sciences, University of L'Aquila Department of Health Sciences, L'Aquila, Italy (Ringgold ID: RIN367958)
2   S.C. Gastroenterologia, Ente Ospedaliero Ospedali Galliera, Genova, Italy (Ringgold ID: RIN9336)
,
Daniele Balducci
3   Università Politecnica delle Marche, Ancona, Italy (Ringgold ID: RIN9294)
,
Antonio Vinci
4   University of Rome Tor Vergata, Roma, Italy (Ringgold ID: RIN9318)
,
Andrea Ghezzi
5   Ente Ospedaliero Ospedali Galliera, Genova, Italy (Ringgold ID: RIN9336)
,
Shirin Djahandideh
5   Ente Ospedaliero Ospedali Galliera, Genova, Italy (Ringgold ID: RIN9336)
,
Stefano Fabiani
6   Pescara Hospital, Pescara, Italy (Ringgold ID: RIN18637)
,
Gianpiero Stefanelli
5   Ente Ospedaliero Ospedali Galliera, Genova, Italy (Ringgold ID: RIN9336)
,
Silvia Buccilli
5   Ente Ospedaliero Ospedali Galliera, Genova, Italy (Ringgold ID: RIN9336)
,
Amedeo Montale
5   Ente Ospedaliero Ospedali Galliera, Genova, Italy (Ringgold ID: RIN9336)
,
7   Gastroenterology and Digestive Endoscopy, Augusto Murri Hospital, Fermo, Italy
,
Luca Maroni
3   Università Politecnica delle Marche, Ancona, Italy (Ringgold ID: RIN9294)
,
Chiara Campanale
5   Ente Ospedaliero Ospedali Galliera, Genova, Italy (Ringgold ID: RIN9336)
› Author Affiliations

Abstract

Background and study aims

Laparoscopic cholecystectomy is the standard treatment for patients with cholecystitis or gallbladder stones after common bile duct (CBD) clearance. According to the sequential strategy, cholecystectomy should be performed within 2 weeks after CDB clearance with endoscopic retrograde cholangiopancreatography (ERCP). However, in real-life experience, the average waiting time is 60 to 180 days. We aimed to evaluate the clinical rationale for prophylactic stent placement in CBD to prevent recurrent biliary events.

Patients and methods

This systematic review and meta-analysis was performed following a protocol designed a priori (PROSPERO: CRD42024564804; July 13, 2024). All published studies involving patients who had undergone ERCP for CBDs and who were awaiting cholecystectomy were included.

Results

At the end of the revision process, four full texts including 755 patients were included in the meta-analysis. The odds ratio (OR) for symptom recurrence in patients awaiting cholecystectomy was 0.74 (95% confidence interval [CI] 0.30-1.79; I2 67%). The pooled OR for adverse event occurrence was 0.74 (95% CI 0.45-1.24) in the stent group. The post-ERCP pancreatitis and cholangitis risk were 0.76 (95% CI 0.25-2.34) and 0.92 (95% CI 0.31-2.67), respectively.

Conclusions

This meta-analysis showed no benefit for stent insertion after bile duct clearance in patients scheduled for delayed cholecystectomy. Further randomized controlled trials with bigger cohorts are needed to assess any benefit for this procedure, which in the meantime, cannot be recommended.

Supplementary Material



Publication History

Received: 27 October 2024

Accepted after revision: 25 January 2025

Accepted Manuscript online:
14 April 2025

Article published online:
12 May 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Marco Valvano, Daniele Balducci, Antonio Vinci, Andrea Ghezzi, Shirin Djahandideh, Stefano Fabiani, Gianpiero Stefanelli, Silvia Buccilli, Amedeo Montale, Filippo Antonini, Luca Maroni, Chiara Campanale. Biliary stent insertion after stone clearance in patients awaiting cholecystectomy: Systematic review and meta-analysis. Endosc Int Open 2025; 13: a25866007.
DOI: 10.1055/a-2586-6007
 
  • References

  • 1 van den Hazel SJ. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. Ann Intern Med 1996; 125: 442-447
  • 2 Harris A, Chong Hen Chan A, Torres-Viera C. et al. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999; 31: 718-724
  • 3 Manes G, Paspatis G, Aabakken L. et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2019; 51: 472-491
  • 4 Cheung YS, Lok HT, Wong KKC. et al. Prolonged cholecystectomy waiting time for complicated gallstone disease was associated with increase rate of gram-negative infection. HPB 2021; 23: S356
  • 5 AL-Osail EM, Bshait MB, Alyami H. et al. The relationship between waiting time for elective cholecystectomy and emergency admission in KFMMC: Single centre experience. Int Surg 2021; 105: 411-416
  • 6 Patriti A, Baiocchi GL, Catena F. et al. Emergency general surgery in Italy during the COVID-19 outbreak: first survey from the real life. World J Emerg Surg 2020; 15: 36
  • 7 Francis N, Dort J, Cho E. et al. SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic. Surg Endosc 2020; 34: 2327-2331
  • 8 Palmisano S, Benvenuto C, Casagranda B. et al. Long waiting lists and health care spending The example of cholecystectomy. Ann Ital Chir 2015; 86: 327-332 http://www.ncbi.nlm.nih.gov/pubmed/26343220
  • 9 Bergeron E, Doyon T, Manière T. et al. Delay for cholecystectomy after common bile duct clearance with ERCP is just running after recurrent biliary event. Surg Endosc 2023; 37: 9546-9555
  • 10 Mori Y, Itoi T, Baron TH. et al. Tokyo Guidelines 2018: management strategies for gallbladder drainage in patients with acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25: 87-95
  • 11 Sasani A, Mandavdhare HS, Sharma V. et al. Role of biliary stent in recurrence of biliary stones and complications after stone clearance in patients awaiting cholecystectomy: A randomized trial. Am J Gastroenterol 2023; 118: 1864-1870
  • 12 Singh AK, Sachdeva S, Chittem R. et al. Role of biliary stenting after stone clearance in patients awaiting cholecystectomy: The jury is still out!. Am J Gastroenterol 2024; 119: 588
  • 13 Choi J-H, Lee T-Y, Cheon Y-K. Effect of stent placement on stone recurrence and post-procedural cholangitis after endoscopic removal of common bile duct stones. Korean J Intern Med 2021; 36: S27-S34
  • 14 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6
  • 15 Sterne JAC, Savović J, Page MJ. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898
  • 16 Sterne JA, Hernán MA, Reeves BC. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919
  • 17 Guyatt G, Oxman AD, Akl EA. et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-394
  • 18 Guyatt GH, Oxman AD, Kunz R. et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395-400
  • 19 Santesso N, Glenton C, Dahm P. et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol 2020; 119: 126-135
  • 20 Mathur MB, Ding P, Riddell CA. et al. Web site and R package for computing E-values. Epidemiology 2018; 29: e45-e47
  • 21 VanderWeele TJ, Ding P. Sensitivity analysis in observational research: Introducing the E-value. Ann Intern Med 2017; 167: 268
  • 22 Smith LH, VanderWeele TJ. Mediational E-values. Epidemiology 2019; 30: 835-837
  • 23 Higgins JPT, Thomas J, Chandler J. , ed. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley Sons; 2019
  • 24 Thorlund K, Engstrøm J, Wetterslev J. et al. User manual for trial sequential analysis (TSA). Copenhagen: Copenhagen Trial Unit; 2017
  • 25 Keizman D, Shalom MI, Konikoff FM. Recurrent symptomatic common bile duct stones after endoscopic stone extraction in elderly patients. Gastrointest Endosc 2006; 64: 60-65
  • 26 Freeman ML, Nelson DB, Sherman S. et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-919
  • 27 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
  • 28 Hormati A, Ghadir MR, Alemi F. et al. Efficacy of common bile duct stenting on the reduction in gallstone migration and symptoms recurrence in patients with biliary pancreatitis who were candidates for delayed cholecystectomy. Dig Dis Sci 2022; 67: 315-320
  • 29 Verzhbitsky V, Zeina AR, Depsames R. et al. Does prophylactic stent insertion to the common bile duct during endoscopic retrograde cholangiopancreatography (ERCP) before cholecystectomy have any impact on the rate of biliary complications?. Surg Endosc 2013; 27: 4620-4624
  • 30 Cianci P, Restini E. Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches. World J Gastroenterol 2021; 27: 4536-4554
  • 31 Jee SL, Jarmin R, Lim KF. et al. Outcomes of early versus delayed cholecystectomy in patients with mild to moderate acute biliary pancreatitis: A randomized prospective study. Asian J Surg 2018; 41: 47-54
  • 32 Lo C-M, Liu C-L, Fan S-T. et al. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg 1998; 227: 461-467
  • 33 Reinders JSK, Goud A, Timmer R. et al. Early laparoscopic cholecystectomy improves outcomes after endoscopic sphincterotomy for choledochocystolithiasis. Gastroenterology 2010; 138: 2315-2320
  • 34 Omar A. Role of biliary stenting for large impacted stone in common bile duct. Egypt J Surg 2020; 39: 505
  • 35 Di Giorgio P, Manes G, Grimaldi E. et al. Endoscopic plastic stenting for bile duct stones: stent changing on demand or every 3 months. A prospective comparison study. Endoscopy 2013; 45: 1014-1017
  • 36 Ye X, Huai J, Sun X. Effectiveness and safety of biliary stenting in the management of difficult common bile duct stones in elderly patients. Turkish J Gastroenterol 2016; 27: 30-36
  • 37 Donelli G, Guaglianone E, Di Rosa R. et al. Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res 2007; 5: 53-60
  • 38 Terada S, Kawaguchi S, Nakatani E. et al. Prospective study on planned biliary stent placement to treat small common bile duct stones. JGH Open 2024; 8: 13040
  • 39 Kawabata H, Kawakatsu Y, Yamaguchi K. et al. Prophylactic biliary stenting before cholecystectomy in patients with gallstones and common bile duct stones. Gastroenterol Res 2019; 12: 191-197
  • 40 Sultan H, Rageh T, Alsoaood A. Necessity of stent placement after successful common bile duct stone clearance by endoscopic retrograde cholangiopancreatography. Menoufia Med J 2019; 32: 1229
  • 41 Nair MS, Uzzaman MM, Fafemi O. et al. Elective laparoscopic cholecystectomy in the presence of common bile duct stent. Surg Endosc 2011; 25: 429-436
  • 42 Ridtitid W, Karuehardsuwan J, Faknak N. et al. Endoscopic gallbladder stenting to prevent recurrent cholecystitis in deferred cholecystectomy: A randomized trial. Gastroenterology 2024; 166: 1145-1155
  • 43 Karsten TM, Davids PH, van Gulik TM. et al. Effects of biliary endoprostheses on the extrahepatic bile ducts in relation to subsequent operation of the biliary tract. J Am Coll Surg 1994; 178: 343-352
  • 44 Li VKM, Yum JLK, Yeung YP. Optimal timing of elective laparoscopic cholecystectomy after acute cholangitis and subsequent clearance of choledocholithiasis. Am J Surg 2010; 200: 483-488